On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors of EyeGate Pharmaceuticals, Inc. effective immediately. Each director’s resignation from the Board was not the result of any disagreements with the company on any matter relating to the company’s operations, policies or practices.